SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: blanka, TheHound, 123tom, kevindenver, TomP1, Rubyred77
Search This Board: 
Last Post: 5/22/2017 9:03:43 PM - Followers: 701 - Board type: Free - Posts Today: 141

Anavex Life Sciences Corp (AVXL)

Company website:
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA

CIK:  0001314052
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s, CNS diseases and various types of cancer, which have significant unmet medical needs.
ANAVEX 2-73, the Company’s orally available drug candidate developed to treat Alzheimer’s through potential disease modification, has undergone an initial Phase 1 human clinical trial and was well tolerated in doses up to 55mg.  Results from pre-clinical studies indicate that ANAVEX 2-73 demonstrates anti-amnesic and neuroprotective properties.
A highly encouraging synergistic effect has also been observed between ANAVEX 2-73 and donepezil (Aricept®).  The combined therapeutics, referred to as “ANAVEX PLUS,” produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually.
ANAVEX PLUS is believed to be a compelling commercial opportunity.  The clinical trial risk is lower because donepezil (Aricept®) is already on the market, with global sales of $4-billion annually.  Donepezil (Aricept®) is now generic and a patent application has been filed for ANAVEX PLUS which, if granted, would provide protection until 2033.

Patent Info:

Clinical Trials:
Recent News:
Company News Releases:
Share Structure:  See SEC filings
Investor Relations:

Marketing Details:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
AVXL News: Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome: Data Prese... 07:00 AM
AVXL News: Statement of Changes in Beneficial Ownership (4) 05/15/2017 05:54:40 PM
AVXL News: Statement of Changes in Beneficial Ownership (4) 05/15/2017 05:54:40 PM
AVXL News: Quarterly Report (10-q) 05/10/2017 04:29:05 PM
AVXL News: Anavex Reports Fiscal Second Quarter 2017 Financial Results 05/10/2017 07:00:00 AM
News News Alert: Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome: Data Prese... 05/22/2017 07:00:00 AM
#103034  Sticky Note To answer your good questions. falconer66a 04/26/17 10:18:09 AM
#101418  Sticky Note OK folks. While we realize that an occasional IH Admin [Edward] 04/18/17 06:45:04 AM
#99603  Sticky Note Basic biology concepts for Alzheimer’s disease (updated 4/1/2017) XenaLives 04/05/17 10:39:21 AM
#94047  Sticky Note Found a nice A-273 profile overview. Rubyred77 03/02/17 02:06:17 PM
#105936   No danger of that bourbon,too many apps for blueyedcatch 05/22/17 09:03:43 PM
#105935   The repatriation of offshore corporate funds will open Talon38 05/22/17 07:57:19 PM
#105934   Attila, As you total up the market Talon38 05/22/17 07:48:19 PM
#105933   If we get approval for one indication, i.e., Reyeton 05/22/17 07:33:31 PM
#105932   You think 1B would go with the shareholder attilathehunt 05/22/17 07:30:15 PM
#105931   Plumer, Great, can you negotiate that deal for Talon38 05/22/17 07:30:06 PM
#105930   I said Merck but meant Pfizer. Merck attilathehunt 05/22/17 07:26:32 PM
#105929   I am praying our treatment is ridiculously cheap??! McMagyar 05/22/17 07:20:39 PM
#105928   We need to get the market cap up Bourbon_on_my_cornflakes 05/22/17 07:20:18 PM
#105927   I wonder since the various foundations are funding attilathehunt 05/22/17 07:13:51 PM
#105926   Talon - I actually think Merck is in attilathehunt 05/22/17 06:57:36 PM
#105925   I think that ship sailed. Good Dr would not McMagyar 05/22/17 06:48:22 PM
#105924   Euphoria prevails. Let sell to Biogen on a mrplmer 05/22/17 06:34:33 PM
#105923   I wonder if the trial for Retts could nFUSZmywallet 05/22/17 05:42:55 PM
#105922   Showing significant results in clinical trials for several nFUSZmywallet 05/22/17 05:40:35 PM
#105921   yes...pressure building...but still acting undecided. 123tom 05/22/17 05:40:30 PM
#105920   Which means that pressure is building.... XenaLives 05/22/17 05:33:05 PM
#105919   The most hopeful aspect is we may contribute kld2 05/22/17 05:29:26 PM
#105918   Kid, Not to prolong this line of discussion Talon38 05/22/17 05:25:35 PM
#105917   ...and "no significant change" in the chart 123tom 05/22/17 05:25:25 PM
#105916   Like it was said in "The DEAL" interview, Penny Double 05/22/17 04:57:39 PM
#105915   Thanks for the support at 5.80. ExtremelyBullishZig 05/22/17 04:52:51 PM
#105914   I questioned the ind existance Bearly Bullish 05/22/17 04:50:51 PM
#105913   Dr. M is adding value to the potential ExtremelyBullishZig 05/22/17 04:46:59 PM
#105911   Honestly, when 65% of phase 1 move to kld2 05/22/17 04:17:08 PM
#105910   SLB chart, updated EOD 22May2017, no significant change wildcard235 05/22/17 04:13:05 PM
#105909   Just checked stocks that I follow on my Tyler_Butler12 05/22/17 04:10:18 PM
#105908   For the P2/3 - they do not need Amatuer17 05/22/17 04:09:43 PM
#105907   Kid, Potential is the operable word. Talon38 05/22/17 04:05:58 PM
#105905   Actually, AF has pointed this out several times kld2 05/22/17 03:56:53 PM
#105904   potential application kld2 05/22/17 03:55:24 PM
#105903   I now believe Dr. Missling is and has tredenwater2 05/22/17 03:45:11 PM
#105902   Had lunch with Congressman Chris Collins, who helped Bourbon_on_my_cornflakes 05/22/17 03:33:13 PM
#105901   T-38 ["Your key point that 2-73 is showing that nidan7500 05/22/17 03:32:12 PM
#105900   Kid, Remember, at the beginning of ever Talon38 05/22/17 03:21:29 PM
#105899   I am hoping for ODD for Angelman, it nFUSZmywallet 05/22/17 03:18:05 PM
#105898   Reminder. We have no way of knowing of TTTav66 05/22/17 02:59:56 PM
#105897   I haven't heard it yet. Still await pk/pd TomP1 05/22/17 02:56:38 PM
#105896   They don't even have an IND for alzheimer's? scottsmith 05/22/17 02:55:17 PM
#105895   I believe the actual statement is 2017. It camk 05/22/17 02:50:46 PM
#105894   Attila, Watch for FDA "Breakthrough Therapy" and additional "Orphan Talon38 05/22/17 02:47:42 PM
#105893   You had to mention AFartstain. Ruined my day-:) rocalinda 05/22/17 02:41:30 PM
#105892   Mc, Did you mention that A2-73 works? rocalinda 05/22/17 02:40:07 PM
#105891   Falconer, Very astute analysis as usual. Talon38 05/22/17 02:34:54 PM
#105890   Without PK/PD data, without and IND, don't think so! TomP1 05/22/17 02:32:53 PM
#105889   When public sentiment says one thing, the complete Fireman02360 05/22/17 02:27:41 PM
#105888   "So many irons in the fire even"--all these plexrec 05/22/17 02:26:44 PM
#105887   Any illness that is wrought by Cellular imbalance McMagyar 05/22/17 02:13:49 PM
#105885   September? They were talking about the 1H; Macfarlane kld2 05/22/17 02:02:35 PM
#105884   No telling what the delay is.. So many irons McMagyar 05/22/17 01:53:48 PM